Background-The mechanisms of the electrocardiographic changes and arrhythmias in Brugada syndrome (BrS) remain controversial. Mutations in the sodium channel gene, SCN5A, and regulatory proteins that reduce or eliminate sodium current (I Na ) have been linked to BrS. We studied the properties of a BrS-associated SCN5A mutation in a protein kinase A (PKA) consensus phosphorylation site, R526H. Methods and Results-In vitro PKA phosphorylation was detected in the I-II linker peptide of wild-type (WT) channels but not R526H or S528A (phosphorylation site) mutants. Cell surface expression of R526H and S528A channels was reduced compared with WT. Whole-cell I Na through all channel variants revealed no significant differences in the steadystate activation, inactivation, and recovery from inactivation. Peak current densities of the mutants were significantly reduced compared with WT. Infection of 2D cultures of neonatal rat ventricular myocytes with WT and mutant channels increased conduction velocity compared with noninfected cells. PKA stimulation significantly increased peak I Na and conduction velocity of WT but not mutant channels. Oxidant stress inhibits cardiac I Na ; WT and mutant I Na decreases with the intracellular application of reduced nicotinamide adenine dinucleotide (NADH), an effect that is reversed by PKA stimulation in WT but not in R526H or S528A channels. Conclusions-We identified a family with BrS and an SCN5A mutation in a PKA consensus phosphorylation site. The BrS mutation R526H is associated with a reduction in the basal level of I Na and a failure of PKA stimulation to augment the current that may contribute to the predisposition to arrhythmias in patients with BrS, independent of the precipitants. (Circ Cardiovasc Genet. 2014;7:249-256.)
M utations in the cardiac sodium channel gene, SCN5A, encoding Na V 1.5 currents can produce of number of heritable diseases of cardiac rhythm and contractile function. Loss-of-function mutations have been associated with sudden cardiac death and ST segment abnormalities in the right precordial leads of the ECG referred to as Brugada syndrome (BrS) . 1 This may be part of a constellation of functional and structural abnormalities of the heart associated with perturbations of the ST segment. [2] [3] [4] 
Clinical Perspective on p 256
BrS is characterized by ECG alterations in the right precordial leads in the absence of structural cardiac abnormalities, preponderance in men particularly of Asian descent, and a high rate of sudden cardiac death. The prevalence of type 1 ECG changes is estimated to be ≈5 of 10,000 5, 6 and more than double that in Japan and other parts of Asia. 7, 8 The updated expert consensus statement on heritable arrhythmias recommends that a diagnosis of BrS be made in the presence of a spontaneous or drug-induced type 1 ECG pattern in ≥1 right precordial lead (V 1 through V 3 ). 9 The genetic mechanisms of BrS have provided insights into the links between metabolism, ion channel function, and cardiac arrhythmias. Approximately 20% of BrS is associated with mutations in SCN5A. 10, 11 In SCN5A-linked BrS, there is a reduction in Na current (I Na ) density that may result from mutations in the channel subunits or in modifiers of Na channel function. Mutations in glycerol phosphate dehydrogenase 1-like (GPD1-L), which is >80% homologous with glycerol phosphate dehydrogenase 1 (GPD1), 12 reduce I Na through June 2014 nicotinamide adenine dinucleotide/reduced nicotinamide adenine dinucleotide (NADH)-dependent mechanisms 13, 14 via activation of protein kinase C (PKC). 15 There is evidence to support a direct effect on Na V 1.5 by PKC phosphorylation 15 and an NADH/PKC-mediated overproduction of reactive oxygen species (ROS) leading to a reduction in expressed I Na . 14 These data suggest that inhibition of I Na by pyridine nucleotides is mediated by mitochondrial-produced ROS and that protein kinase A (PKA) activation may block ROS-induced reduction of the current and constitutes a treatment strategy for patients with BrS. 13, 16 We studied a mutation in a patient with BrS presenting with a spontaneous type 1 ECG and history of syncope to elucidate the mechanism(s) of I Na reduction and its reversal by adrenergic activation. Our data suggest a mechanism for the ECG changes and arrhythmias in BrS initiated by altered metabolism and an increase in oxidant burden that is not mitigated by β-adrenergic stimulation.
Materials and Methods
Detailed methods are provided in the Data Supplement. Molecular biological reagents including lentiviral vectors [17] [18] [19] and ion channel plasmids were generated as previously described. 20 All protocols followed US Department of Agriculture and National Institutes of Health guidelines and were approved by the Animal Care and Use Committee of the Johns Hopkins Medical Institutions.
Neonatal rat ventricular myocytes (NRVMs) were enzymatically isolated 21 and transduced as previously described. 18, 22 Optical mapping was performed on plated monolayers of NRVMs, and data were analyzed using custom-written scripts in MATLAB (Mathworks, Natick, MA). 22 Whole-cell I Na was measured under voltage clamp at room temperature (22°C) as previously described. 23 The bath and pipette solutions are described in the Data Supplement. Recombinant human Na V 1.5 peptides were expressed in Escherichia coli, purified, and incubated with PKA in the presence of γP 32 -labeled ATP. HEK 293 cells were transformed with wild-type (WT) Na V 1.5, R526H, and S528A Na V 1.5 plasmids. Cell membrane proteins were labeled with biotin and captured on streptavidin beads. Total and membrane-bound Na V 1.5 expression was determined by Western blotting using an anti-Na channel antibody (Sigma S8809).
The results are presented as mean±SD or SEM. Statistical comparisons were made using a 1-way ANOVA followed by Bonferroni/ Dunn tests for multiple comparisons, and serial studies were assessed by repeated-measures ANOVA. Statistical significance was assumed at P<0.05.
Results
The patient is a 33-year-old man who presented with 2 syncopal spells in rapid succession during micturition and without premonitory symptoms. In the field, he had a normal heart rate and blood pressure. He had experienced palpitations after vigorous exercise in the past but had never had syncope. There was a family history of a paternal aunt who died suddenly around age 40 of unknown causes and a maternal uncle with Down Syndrome who died suddenly at age 11 in the setting of a febrile illness. The mutation was transmitted maternally, and the proband's mother had multiple episodes of syncope and near syncope associated with migraine headaches which were felt to be vasodepressor. Her baseline ECG exhibited 0.5-to 1-mm J-point elevation in leads V 1 and V 2 and a saddleback segment in V 2 ; after procainamide infusion, both V 1 and V 2 ST segments were changed into a coved type ( Figure SI in the Data Supplement). The patient's younger sister carries the mutation and has a baseline incomplete right bundle-branch block (RBBB), which did not change with procainamide infusion. B, A schematic of the Na V 1.5 pore-forming α-subunit and the β1 and β2 subunits. The disease-causing mutation (R526H) is in the I-II interdomain linker of Na V 1.5 in a canonical protein kinase A (PKA) phosphorylation recognition sequence. The residue 2 amino acids C-terminal to R526, S528 was mutated to alanine in this study. C, In vitro phosphorylation of I-II linker peptides. Purified fragments were incubated with PKA and calcium-calmodulin kinase II δ (CaMKII) in the presence of γP 32 -labeled ATP. The labeled peptides were separated by polyacrylamide gel electrophoresis (PAGE). Mutant peptides R526H and S528A are not labeled by PKA but are phosphorylated as efficiently as wild type (WT) in the presence of CaMKII.
His 12-lead ECG revealed coved ST segments in leads V 1 and V 2 consistent with a Brugada type 1 ECG pattern ( Figure 1A) . A transthoracic echocardiogram was normal. A single-chamber defibrillator was implanted.
BrS Mutation Disables PKA Phosphorylation
DNA sequencing of SCN5A revealed a nucleotide transition at position 1577 encoding a missense mutation at codon 526 changing an arginine to histidine (R526H, Figure 1B ). The minor allele frequency from the exome variant server is 0.016% 24 and is a chemically and structurally conservative change. 25, 26 However, the mutation resides in a PKA recognition sequence in the I-II interdomain linker of the channel, with serine 528 (S528) as the phosphorylated residue.
The I-II linker of Na V 1.5 contains consensus phosphorylation sites for several kinases including PKA and calcium calmodulin kinase II. We created mutant I-II linker peptides with the clinical mutation, R526H, and at the putative phosphorylation site, S528A. In vitro phosphorylation by PKA revealed complete elimination of 32 P incorporation into the R526H and S528A peptides. By contrast, calcium calmodulin kinase II phosphorylated all channel peptides equally ( Figure 1C ). 
Altered Channel Regulation in Response to Stress
We speculate that stressors that reduce I Na density (oxidants, fever, and Na channel blocking drugs) may, in part, be offset by PKA stimulation of the channel. To study the functional effects of these mutations in response to PKA phosphorylation, we expressed WT and mutant Na V 1.5 currents in HEK 293 cells. Selected families of currents in standard recording solutions revealed current densities through the mutant channels that were only modestly smaller than WT but not different from each other in the absence of PKA stimulation (Figure 2A and 2B). The baseline whole-cell properties including the current-voltage (I-V) relationships, voltage dependence and kinetics of gating, and kinetics of current decay were not different between WT and the mutants ( Figure 2C ; Table SI in the Data Supplement). In the presence of PKA, WT Na V 1.5 currents were significantly upregulated with a hyperpolarizing shift in the peak I-V and activation curves ( Figure 2 ) and hastened recovery from inactivation ( Table SI in the Data  Supplement) . By contrast, neither the peak current, voltage dependence of gating, or recovery kinetics ( Figure 2 ; Table   SI in the Data Supplement) of R526H or S528A were significantly affected by the addition of PKA.
Oxidative stress and an increase in glycolysis will lead to increased levels of cytosolic NADH, which rapidly decreases I Na . We recorded currents in a metabolic stabilizing solution (see Methods in Data Supplement, inhibiting kinases and phosphatases) to examine the effect of intracellular NADH on the WT and mutant currents. The baseline peak density of the WT current was significantly larger than either R526H or S528A mutant currents ( Figure 3A-3C ). The addition of 100 μmol/L NADH to the pipette solution reduced the average I Na by >50% in all channel variants ( Figure 3A and 3B ). The addition of NADH had no significant effect on the decay kinetics or voltage dependence of gating of WT Na V 1.5 or the mutant channels ( Figure 3E ; Table  SII in the Data Supplement). We speculated that the current density might be restored by PKA in the setting of an increase in NADH and that this restoration might be compromised in the mutant channels. To study the effect of activation of PKA signaling on NADH-induced suppression of Na V 1.5 current, cells were incubated with forskolin and 8-Br cAMP for 20 minutes . NADH reduces the current through all channel variants, whereas PKA activation does not increase the current density through the mutant channels. C, Bar plots of peak current densities of WT (black), R526H (blue), and S528A (red) under basal conditions. D, Summary bar plots for WT, R526H, and S528A channel peak current density at baseline (open bars) with NADH (gray bars) and NADH+PKA activation (black bars). E, Activation and steady-state inactivation curves in the absence (open circles activation, open triangles inactivation) and presence of NADH (gray circles activation, gray triangles inactivation) and NADH + PKA stimulation (filled circles activation, filled triangles inactivation) for each of the channel variants; there are no significant differences in any of the variants under any of the conditions. prior to patch clamp recording. Incubation with forskolin and 8-Br cAMP completely reversed the downregulation of WT Na V 1.5 current by intracellular NADH (Figure 3A , 3B, and 3D) and produced a modest but significant hyperpolarizing shift in the voltage dependence of activation gating (Table SII in the  Data Supplement) . The reductions in R526H and S528A currents by NADH were not affected by the addition of forskolin and 8-Br cAMP ( Figure 3D ; Table SII in the Data Supplement).
Trafficking of Mutant Channels
The reduction in basal current density of R526H and S528A channels without a change in biophysical characteristics compared with WT suggested the possibility of an alteration in trafficking to the surface membrane. Surface membrane expression of WT and mutant Na V 1.5 channels in HEK 293 was quantified by labeling intact cells with biotin and purifying the protein on immobilized streptavadin. Overall expression of the channel proteins did not differ; however, Figure 4A illustrates that even with less WT Na V 1.5 protein in the total lysate, a greater proportion of the WT channel was biotinylated compared with both the R526H and S528A mutants ( Figure 4B ).
To study trafficking in a cardiac cell background, NRVMs were infected with lentiviruses containing the WT or mutant channels fused to enhanced green fluorescent protein (eGFP) at the carboxyl terminus. The channel-infected NRVMs were cotransfected with an endoplasmic reticulum marker dsRED-ER. Consistent with the biotinylation experiments, NRVMs infected with the viruses encoding the R526H and S528A mutants exhibited more channel protein in subcellular membranes, colocalized with dsRED-ER compared with WT channels ( Figure 4C and 4D ).
Effect of Mutants on Conduction Velocity
The functional consequences of the reduced surface expression and altered regulation of the mutant channels were studied using optical mapping of 2D cultures of NRVMs. To control for variability in baseline conduction velocities (CVs), cultures that were transduced with Na channel variants were compared with naïve nontransfected cultures. The cultures were stimulated over a range of pacing cycle lengths (175-500 ms) to determine the CVs; isochronal maps at baseline and in the presence of isoproterenol are shown for WT, R526H, and S528A transfected cultures ( Figure 5A ). The baseline CVs of NRVM cultures infected with WT Na V 1.5 and the mutant channels were similar and ≈20% to 50% (5-10 cm/s) faster than nontransfected cultures over a range of pacing cycle lengths ( Figure 5B ). At more rapid pacing rates, accumulation of ROS is anticipated, which would decrease I Na . The CVs of the WT and mutant channel-transduced cultures are greater than that of nontransfected control cultures at slower pacing rates; at faster rates, the difference is diminished and no longer significant at a pacing cycle length of 180 ms ( Figure 5B ). The CVs of the WT-infected cultures are significantly increased by exposure to isoproterenol while that of the mutant-infected cultures are no more responsive than nontransfected control cultures ( Figure 5C ).
Discussion
Mutations in the Na channel, SCN5A, 10 or regulatory proteins such as GPD1-L 12 that reduce current have been associated with BrS and sudden infant death syndrome (SIDS). In both conditions, arrhythmias are more prevalent under conditions of various types of stress (oxidant stress, fever, ischemia, and Na channel blocking drugs). We describe an SCN5A mutation in a patient with BrS that produces both a chronic reduction in I Na and absence of augmentation of the current by adrenergic stimulation. Interestingly, the reduction in the basal current produced by the R526H and S528A mutations compared with WT Na V 1.5 is more pronounced when fluoride is included in the patch pipette to inhibit protein phosphatase, consistent with increased basal phosphorylation of the WT channel. The elimination of a PKA site seems to be central to both the signaling and trafficking deficits. The disease-causing mutation, R526H, which is chemically and structurally conservative, 25, 26 eliminates the basic priming residue in a consensus PKA phosphorylation recognition sequence. Replacement of the phosphorylation target residue, S528A, alters channel trafficking and regulation by PKA in a manner that is comparable to the disease-causing mutation and similar to previously described defects in PKA-mediated I Na potentiation. 27 The mutations reduce channel expression at the membrane surface as assessed by biotinylation and immunocytochemistry studies ( Figure 4) and are reflected in a lower expressed current density in HEK cells (Figure 3) .
The reduction in I Na is further complicated by the absence of a response of the channel to adrenergic stimulation. Neither the direct activation of adenylyl cyclase nor β-adrenergic stimulation with isoproterenol had a significant effect on current density or CV mediated by the mutant channel variants. These findings suggest a mechanism of stress-induced arrhythmias that may be due to changes of cellular redox balance with alterations in the ratio of NAD/NADH and consequent reduction in I Na . Such metabolic stressors are typically accompanied by activation of the sympathetic nervous system that may partially offset the redoxinduced reduction in I Na and would dampen stress-induced ECG changes in BrS and alterations in CV. In such cases, arrhythmias would not be predicted to be induced by sympathetic activation but instead would be mitigated by an increase in sympathetic tone. This concept is consistent with the utility of isoproterenol in the treatment of arrhythmic storm in patients with BrS. [28] [29] [30] There are several mechanisms by which metabolism has been proposed to alter the I Na . Direct oxidation of the channel can alter channel conductance, 31, 32 gating, 33, 34 and trafficking. 35 Mutations associated with BrS have informed other mechanisms of metabolic regulation of Na channels. NADH is generated from NAD during glycolysis, and NAD must be regenerated for glycolysis to continue. GPD1 reduces dihydroxyacetone phosphate to glycerol-3-phosphate, causing oxidation of NADH and regeneration of NAD with the electrons released from this reaction entering the electron transport chain. GPD1-L is highly homologous to GPD1 and harbors mutations associated with BrS. 12 When mutant GPD1-L is coexpressed with Na V 1.5, I Na is significantly reduced. [12] [13] [14] [15] The BrS mutations have been proposed to reduce the enzymatic function of GPD1-L and would be expected to increase intracellular NADH levels. An increase in NADH possibly via activation of PKC, 13 enhancing phosphorylation of complex III resulting in an increase in ROS release, 14 reduces channel function. Alternatively, inactivating mutants of GPD1-L have been proposed to increase PKC phosphorylation of the Na channel in the III-IV linker, reducing current density. 15 Increased mitochondrial ROS release, elevated levels of NADH, and PKC activation have been implicated in I Na downregulation in models of nonischemic cardiomyopathy and in CV slowing in diseased human ventricles. 36 Our work supports another mechanism of coupling of metabolism to channel function through altered PKA activation. 27 Increased NADH causes a reduction in current through WT and mutant R526H-and S528A-expressed channels. The absence of the PKA phosphorylation site in the mutant channels precludes current augmentation in the setting of sympathetic activation.
The mechanism of arrhythmias in this SCN5A-mediated BrS seems to involve a substrate that is characterized by decreased basal current expression as a result of altered mutant channel trafficking. Although it is difficult to infer general mechanisms from a single family, this disease-causing mutation produces the requisite basal reduction in I Na compounded by defective current augmentation that generates the substrate for a potentially lethal arrhythmias. A trigger that further reduces I Na , through any number of mechanisms such as alterations in glycolysis, ROS levels, or PKC activation, cannot be mitigated by PKA activation, leading to a further reduction in current. The absence of a PKA-mediated reversal of NADH-induced current reduction (Figure 3) is consistent with the lack of effect on conduction in infected NRVMs. The reduction of I Na could alter either regional dispersion of repolarization or conduction in the heart; one or both may contribute to the genesis of the potentially lethal ventricular arrhythmias in patients harboring this mutation.
